Stockreport

23andMe to Report Q2 FY2025 Financial Results

23andMe Holding Co.  (ME) 
PDF SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced toda [Read more]